Publications by Medical Specialty - Cardiology
These publications were authored or co-authored by Quest Diagnostics staff.
- Clinical and Lab healthcare professionals
- Endocrinology, Diabetes & Metabolism
- Family medicine practitioners
- General Health and Wellness
- Geriatrics/Age Management
- Health Information Technology
- Infectious Disease
- Internal Medicine
- Nurse practitioners
- Pathology, Anatomic
- Pathology, Laboratory Medicine
- Physician assistants
- Prescription Drug Monitoring
- Sports Medicine
- Toxicology/Pain Management
- Women's Health/OB/GYN
Authors: Iakoubova O, Tong C, Catanese J, Rowland C, Luke M, Tranquilli M, Elefteriades JA
Aorta (Stamford). 2016;4:83-90
Authors: Taylor SW, Clarke NJ, Chen Z, McPhaul MJ.
Clin Chim Acta. 2016;455:202-208
Neighborhood Socioeconomic Status in Relation to Serum Biomarkers in the Black Women's Health Study.
Authors: Cozier YC, Albert MA, Castro-Webb N, Coogan PF, Ridker P, Kaufman HW, Palmer JR, Rosenberg L.
J Urban Health. 2016;93:279-291
Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history.
Authors: Tada H, Melander O, Louie JZ, Catanese JJ, Rowland CM, Devlin JJ, Kathiresan S, Shiffman D.
Eur Heart J. 2016;37:561-567
Authors: Haymond S, Clarke NJ, Reitz RE, McPhaul MJ, Wu Z.
Clin Chem. 2016;62:408-409
Mutational Analysis in Pediatric Thyroid Cancer and Correlations with Age, Ethnicity, and Clinical Presentation.
Authors: Nikita ME, Jiang W, Cheng SM, Hantash FM, McPhaul MJ, Newbury RO, Phillips SA, Reitz RE, Waldman FM, Newfield RS.
Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.
Authors: Mora S, Caulfield MP, Wohlgemuth J, Chen Z, Superko HR, Rowland CM, Glynn RJ, Ridker PM, Krauss RM
Authors: Kroll MH1, Garber CC, Bi C, Suffin SC.
Arch Pathol Lab Med. 2015;139:1295-301
Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis.
Authors: Shiffman D, Perez MV, Bare LA, Louie JZ, Arellano AR, Devlin JJ
BMC Cardiovasc Disord. 2015;15:104